Harbin Gloria Pharmaceuticals Cash Flow Quality Index
Harbin Gloria Pharmaceuticals cash flow quality index. Harbin Gloria Pharmaceuticals (002437) has a Cash Flow Quality Index of 1.67x as of September 2025. Operating cash flow of CN¥182.89 Million exceeds net income of CN¥109.34 Million, indicating high earnings quality where cash backs reported profits. See 002437 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Harbin Gloria Pharmaceuticals (2007–2025)
Cash flow quality index of Harbin Gloria Pharmaceuticals from 2007 to 2025. Historical Cash Flow Quality Index for Harbin Gloria Pharmaceuticals across 17 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 002437 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Harbin Gloria Pharmaceuticals Cash Flow Quality Index by Year (2007–2025)
Harbin Gloria Pharmaceuticals cash flow quality index by year from 2007 to 2025. Year-by-year earnings quality comparison for Harbin Gloria Pharmaceuticals. For the full cash flow conversion analysis, see cash efficiency ratio of Harbin Gloria Pharmaceuticals.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.73x | CN¥273.36 Million | CN¥376.91 Million | ▼ -57.2% |
| 2024 | 1.69x | CN¥410.94 Million | CN¥242.54 Million | ▼ -20.5% |
| 2023 | 2.13x | CN¥274.18 Million | CN¥128.70 Million | ▼ -58.2% |
| 2021 | 5.09x | CN¥274.18 Million | CN¥53.84 Million | ▲ +16206.3% |
| 2020 | 0.03x | CN¥12.76 Million | CN¥408.68 Million | ▼ -99.7% |
| 2018 | 9.03x | CN¥1.16 Billion | CN¥128.77 Million | ▲ +322.9% |
| 2017 | 2.14x | CN¥651.80 Million | CN¥305.27 Million | ▲ +49.5% |
| 2016 | 1.43x | CN¥1.04 Billion | CN¥728.40 Million | ▲ +42.6% |
| 2015 | 1.00x | CN¥702.05 Million | CN¥701.03 Million | ▼ -32.3% |
| 2014 | 1.48x | CN¥674.04 Million | CN¥455.66 Million | ▼ -25.0% |
| 2013 | 1.97x | CN¥453.02 Million | CN¥229.60 Million | ▲ +56.7% |
| 2012 | 1.26x | CN¥205.89 Million | CN¥163.47 Million | ▲ +14.1% |
| 2011 | 1.10x | CN¥128.61 Million | CN¥116.51 Million | ▲ +51.7% |
| 2010 | 0.73x | CN¥112.59 Million | CN¥154.71 Million | ▼ -44.5% |
| 2009 | 1.31x | CN¥170.82 Million | CN¥130.24 Million | ▲ +140.4% |
| 2008 | 0.55x | CN¥57.81 Million | CN¥105.95 Million | ▼ -21.9% |
| 2007 | 0.70x | CN¥52.26 Million | CN¥74.76 Million | — |